The U.S. Food and Drug Administration is reporting that some propafenone HCL tablets are being recalled. Propafenone HCL is a drug used to treat cardiac arrhythmias. According to drugmaker Watson Pharmaceuticals, some lots of propafenone HCL 225 mg tablets sold in 100-count bottles in the United States are being voluntarily recalled because some tablets might contain slightly higher levels of the active ingredient than specified. The recalled tablets were shipped to customers between October 15...
Read morePaxil - generic paroxetine - is an antidepressant that works by increasing the amount of serotonin between nerve cells in the brain, which... Read more »
BP-3 or Benzophenone-3 is a sunscreen ingredient that you will typically find in sun protection products, skin care lotions, lipsticks,... Read more »
My secret ingredient this week will add zip to almost any sandwich, salad - even breakfast eggs - without adding calories, excess sodium or... Read more »
There is ongoing discussion about what policies will help to make a dent on the current obesity trend. San Francisco has moved to force... Read more »
September is National Cholesterol Education Month, so it's a great time to think about having your cholesterol checked, and to take steps... Read more »
The U.S. Food and Drug Administration (FDA) is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx,... Read more »
The ingredient that puts the "pep" in hot peppers may also cause weight loss, South Korean researchers say. Capsaicin appears to trigger proteins... Read more »
Results from a new study suggest that some parts of the Mediterranean diet are more beneficial to good health than others. In a new study at the... Read more »
Every year, new skin-care treatments come out promising amazing results, and while some of these deliver on their promises, others do not. Reporters... Read more »
Many people take red yeast rice supplements because of claims that the products can improve cholesterol levels. But new research published in the... Read more »